These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10065805)

  • 1. Low and high responders--at what levels of serum estradiol do things start to get fuzzy?
    Check JH
    Fertil Steril; 1999 Mar; 71(3):582-3; author reply 584-6. PubMed ID: 10065805
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of the high peak serum estradiol on the outcome of in vitro fertilization cycles].
    Carmona-Ruiz IO; Galache-Vega P; Santos-Haliscak R; Díaz-Spíndola P; Batiza-Reséndiz VA; Hernández-Ayup S
    Ginecol Obstet Mex; 2010 Oct; 78(10):553-8. PubMed ID: 21966773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization-embryo transfer cycles.
    Lindheim SR; Cohen MA; Chang PL; Sauer MV
    J Assist Reprod Genet; 1999 May; 16(5):242-6. PubMed ID: 10335470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Serum FSH is Associated with Brown Oocyte Formation and a Lower Pregnacy Rate in Human IVF Parctice.
    Xu H; Deng K; Luo Q; Chen J; Zhang X; Wang X; Diao H; Zhang C
    Cell Physiol Biochem; 2016; 39(2):677-84. PubMed ID: 27442586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibin B predicts oocyte number and the ratio IGF-I/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization.
    Fried G; Remaeus K; Harlin J; Krog E; Csemiczky G; Aanesen A; Tally M
    J Assist Reprod Genet; 2003 May; 20(5):167-76. PubMed ID: 12812459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low and high responders--at what levels of serum estradiol do things start to get fuzzy?
    Sharara FI
    Fertil Steril; 1999 Mar; 71(3):583-6. PubMed ID: 10065806
    [No Abstract]   [Full Text] [Related]  

  • 7. Basal serum levels of FSH and estradiol in ovulatory and anovulatory women undergoing treatment by in-vitro maturation of immature oocytes.
    Child TJ; Sylvestre C; Pirwany I; Tan SL
    Hum Reprod; 2002 Aug; 17(8):1997-2002. PubMed ID: 12151427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of basal estradiol-17beta predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization.
    Evers JL; Slaats P; Land JA; Dumoulin JC; Dunselman GA
    Fertil Steril; 1998 Jun; 69(6):1010-4. PubMed ID: 9627285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization.
    Berin I; Stein DE; Keltz MD
    Fertil Steril; 2010 Feb; 93(2):360-3. PubMed ID: 19131055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].
    Grzegorczyk-Martin V; Khrouf M; Bringer-Deutsch S; Mayenga JM; Kulski O; Cohen-Bacrie P; Benaim JL; Belaisch-Allart J
    Gynecol Obstet Fertil; 2012; 40(7-8):411-8. PubMed ID: 22521986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome.
    Eldar-Geva T; Ben-Chetrit A; Spitz IM; Rabinowitz R; Markowitz E; Mimoni T; Gal M; Zylber-Haran E; Margalioth EJ
    Hum Reprod; 2005 Nov; 20(11):3178-83. PubMed ID: 16113044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible factors affecting the development of oocytes in in-vitro maturation.
    Mikkelsen AL; Smith S; Lindenberg S
    Hum Reprod; 2000 Dec; 15 Suppl 5():11-7. PubMed ID: 11263532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal serum follicle stimulating hormone (FSH) and estradiol levels as predictors of pregnancy in unstimulated donor insemination cycles.
    Witt BR; Barad DH; Barg P; Cohen BL; Lindheim SR; Testaiuti L; Amin HK
    J Assist Reprod Genet; 1995 Mar; 12(3):157-60. PubMed ID: 8520178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization.
    Orvieto R; Zohav E; Scharf S; Rabinson J; Meltcer S; Anteby EY; Homburg R
    Gynecol Endocrinol; 2007 Feb; 23(2):72-5. PubMed ID: 17454155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of agonist dose on in-vitro fertilization.
    Lashen H; Ledger W
    Hum Reprod; 1998 Oct; 13(1O):2973-4. PubMed ID: 9804266
    [No Abstract]   [Full Text] [Related]  

  • 17. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
    Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
    Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients.
    Grifo JA; Noyes N
    Fertil Steril; 2010 Feb; 93(2):391-6. PubMed ID: 19439285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders.
    Padilla SL; Dugan K; Maruschak V; Shalika S; Smith RD
    Fertil Steril; 1996 Apr; 65(4):796-9. PubMed ID: 8654641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.